Anonymous ID: b7b6f5 Dec. 6, 2019, 4:23 p.m. No.7442996   🗄️.is đź”—kun   >>3080 >>3184 >>3245 >>3287 >>3290 >>3424

Sweden's Ericsson to pay over $1bn to settle US corruption probe

 

Sweden's telecoms giant Ericsson has agreed to pay more than $1bn (ÂŁ760m) to resolve allegations of bribery, the US Department of Justice has announced.

 

It said the company had "admitted to a years-long campaign of corruption in five countries to solidify its grip on telecommunications business". It added that Ericsson had entered into a deferred prosecution agreement in connection with criminal charges filed in a New York court. Ericsson has so far made no comment.

 

The firm is one of world's biggest makers of mobile network equipment. In September, it said it had put aside $1.2bn to cover possible penalties stemming from the US investigation.

The settlement is believed to be one of the highest ever under the Foreign Corrupt Practices Act (FCPA).

 

It involves a $520m criminal penalty to the justice department and a payment of $540m to the Securities and Exchange Commission (SEC).

What did the US justice department say?

 

Its statement said that Ericsson had agreed to pay the penalty to "resolve the government's investigation into violations of the Foreign Corrupt Practices Act (FCPA) arising out of the Company's scheme to make and improperly record tens of millions of dollars in improper payments around the world".

 

"Through slush funds, bribes, gifts, and graft, Ericsson conducted telecom business with the guiding principle that 'money talks'," said US Attorney Georffrey S Berman of the Southern District of New York.

 

"Today's [Friday's] guilty plea and surrender of over a billion dollars in combined penalties should communicate clearly to all corporate actors that doing business this way will not be tolerated," he added. The department said that Ericsson had operated its corrupt scheme "beginning in 2000 and continuing until 2016". The US justice department named the five countries involved as Djibouti, China, Vietnam, Indonesia and Kuwait.

 

https://www.bbc.com/news/world-us-canada-50695438

Anonymous ID: b7b6f5 Dec. 6, 2019, 4:45 p.m. No.7443153   🗄️.is đź”—kun   >>3184

Dicerna Pharmaceuticals sold by Bain Capital (Life Sciences):$37.02m-Dec 4

 

Plus recent Nov sale.

 

Dicerna Pharmaceuticals, Inc. is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based on its RNA interference (RNAi) technology platform. It is focused on development of RNAi-based therapeutics using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare diseases, viral infectious diseases, chronic liver diseases and cardiovascular diseases. Its development programs include dacryocystorhinostomy (DCR)-PHXC for the treatment of primary hyperoxaluria (PH), which is in a Phase I clinical trial; DCR-HBVS for the treatment of chronic hepatitis B virus (HBV), which is in a Phase I clinical trial, and a product candidate against a rare liver disease. It also developed a wholly owned clinical candidate, DCR-BCAT, targeting the β-catenin oncogene. DCR-BCAT is delivered by its lipid nanoparticle (LNP) tumor delivery system, EnCore.

 

————————————————

 

Dr. Adam M. Koppel is Managing Director of Bain Capital Life Sciences. He initially joined Bain Capital Public Equity in 2003, where he worked as a leader within the healthcare sector until 2014. From 2014 to 2016, Adam was EVP of Corporate Development and Chief Strategy Officer at Biogen.

 

Adam sits on the Board of Directors of Solid Biosciences, Dicerna Pharmaceuticals, Aptinyx, and Foghorn Therapeutics. Adam also sits on the Newton-Wellesley Hospital Board of Trustees, the Partners Healthcare Innovation Advisory Board, and the Society for Neuroscience Investment Committee. He serves on the Board of Trustees of the Boston Museum of Science. In addition, He previously sat on the Board of Temple Beth Elohim in Wellesley, Massachusetts, from 2014 to 2017.

 

Adam received an M.D. and Ph.D. in neuroscience from the University of Pennsylvania School of Medicine. He also received an MBA from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar. He graduated magna cum laude from Harvard University with bachelor’s degrees in history and science.

https://www.cerevel.com/perception-team/adam-koppel-m-d-ph-d/

https://www.finviz.com/insidertrading.ashx?oc=1578965&tc=7&b=2

Anonymous ID: b7b6f5 Dec. 6, 2019, 5:39 p.m. No.7443461   🗄️.is đź”—kun

POTUS perfectly orchestrates the stock market’s rise whenever momentum wanes

 

The POTUS Put

 

President Trump has successfully turned a segment of stock market investors into puppy dogs. Just witness trading this week.

 

At the same time, Republicans are beginning to tie Trump’s hands in small ways. Let’s explore these issues with the help of two charts.

 

caps 2 & 3

 

The first chart shows that the Dow fell over 400 points on Trump’s comments that it might be best to complete the phase-one trade deal with China after the election.

 

• The first chart shows that the very next day, the Dow jumped over 200 points on Trump’s comments that talks with China were going well.

 

• The first chart shows that Trump has been orchestrating the stock market’s rise with his near-perfectly timed comments. Please see “President Trump might just be the best stock market timer ever.”

 

• The second chart gives you a better perspective of the technical condition of the market. The chart shows two prior patterns combining the price action, internal momentum and volume that are similar to the present pattern in the stock market. In both prior cases, the stock market declined. For details on interpreting the chart and other relevant macro data, please read “Believe in a Santa Claus rally if you want, but first look at this chart.”

 

• The U.S. Senate is getting ready to vote on a bill for sanctions against China for internment of over one million Uighur Muslims in the Xinjiang province in northwest China.

 

• Republicans are getting up the nerve to join Democrats to pass the bill.

 

• The bill is likely to have a veto-proof majority.

 

• Investors should note that Republicans are joining Democrats to force Trump to sign the bill, which would certainly anger China.

 

• Previously Republicans joined Democrats to pass a bill to support democracy in Hong Kong. Since the bill was passed with a veto-proof majority, Trump was left with no good choice but to sign it.

 

This stock market is controlled by the momo crowd. Clearly Trump understands that the momo crowd is fickle and can be moved in either direction based on momentum in the stock market. This is the reason that Trump is able to manipulate the momo crowd into behaving like puppy dogs.

 

The prevailing wisdom among the momo crowd is that the stock market will jump up 5%-15% on phase one of the trade deal.

https://www.marketwatch.com/story/trump-perfectly-orchestrates-the-stock-markets-rise-whenever-momentum-wanes-2019-12-05

'a rare habbening now..financial press being straight-forward while not being a political hack.

 

https://www.marketwatch.com/story/trump-perfectly-orchestrates-the-stock-markets-rise-whenever-momentum-wanes-2019-12-05

Anonymous ID: b7b6f5 Dec. 6, 2019, 5:52 p.m. No.7443542   🗄️.is đź”—kun

>>7443509

the only reason that movie was allowed to be made is that it let's everyone know..it still goes on no matter what habbens.

The Irons character is Dick Fuld at Lehman Bro's. His name is even Tuld.

There are parts of it that are true but some very disingenuous moments as well.

Lehman was a orchestrated event and not left to one group of fuck-up bankers to decide whether they would pull the pin first-as the movie postulates.